Klaus Pfizenmaier

机构：University of Stuttgart, Stuttgart Technical University of Applied Sciences · ORCID：0000-0002-3441-9227

发表论文 359 篇 · 总被引 20894 次 · h-index 75

代表论文

• Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis (2023 · Journal of Neuroinflammation · 被引 32)
• The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration (2023 · Scientific Reports · 被引 21)
• Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS (2023 · Journal of Neuroinflammation · 被引 21)
• Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis (2024 · Brain Research Bulletin · 被引 6)
• Single intracerebroventricular TNFR2 agonist injection impacts remyelination in the cuprizone model (2025 · Journal of Molecular Medicine · 被引 3)
• Comparison of antibody-scTRAIL Fc fusion proteins with varying valency for EGFR and TRAIL receptors (2025 · Scientific Reports)